Nigerian trade groups call on government for more pharma R&D

17 July 2012

Speaking at the Pharmaceutical Manufacturers' Group of the Manufacturers Association of Nigeria annual meeting in Lagos, president of the trade group, Bunmi Olaopa, called on the federal government to invest more in R&D and at the same time stating that mergers and acquisition is the way forward in growing the pharmaceutical manufacturing industry in Africa, reports the AllAfrica news service.

Mr Olaopa, identified concerted effort as one of the most effective options towards molding pharmaceutical firms in Africa to stand firm in the global environment and thrive successfully. He also expressed displeasure at the fact that only four African manufacturers were listed by the World Health Organization’s pre-qualification program, with none coming from the West African sub-region.

Failing to keep pace with global trends

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK







Today's issue

Company Spotlight



More Features in Pharmaceutical